Symbols / CARA
CARA Chart
About
No company description available for this symbol.
Fundamentals
Scroll to Statements| Sector | — | Industry | — | Market Cap | — |
| Enterprise Value | — | Income | — | Sales | — |
| Book/sh | — | Cash/sh | — | Dividend Yield | — |
| Payout | — | Employees | — | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | — | P/B | — | P/C | — |
| EV/EBITDA | — | EV/Sales | — | Quick Ratio | — |
| Current Ratio | — | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | — | EPS next Y | — | EPS Growth | — |
| Revenue Growth | — | Earnings | 2024-11-14 16:00 | ROA | — |
| ROE | — | ROIC | — | Gross Margin | — |
| Oper. Margin | — | Profit Margin | — | Shs Outstand | — |
| Shs Float | — | Short Float | — | Short Ratio | — |
| Short Interest | — | 52W High | — | 52W Low | — |
| Beta | — | Avg Volume | — | Volume | — |
| Target Price | — | Recom | — | Prev Close | — |
| Price | — | Change | — |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
No analyst ratings or price targets available.
- Cara Therapeutics announces 1-for-3 reverse stock split related to Tvardi merger - Hartford Business Journal ue, 15 Apr 2025 07
- Cara Therapeutics Announces 1-for-3 Reverse Stock Split in Connection with the Proposed Merger with Tvardi Therapeutics - Yahoo Finance Mon, 14 Apr 2025 07
- Tvardi's STAT3 inhibitor flunks phase 2 IPF trial amid high dropout rates - Fierce Biotech Mon, 13 Oct 2025 07
- Tvardi Therapeutics Announces Closing of Merger with Cara Therapeutics - GlobeNewswire ue, 15 Apr 2025 07
- Cara Therapeutics announces merger with Tvardi Therapeutics - Investing.com Mon, 24 Mar 2025 07
- Tvardi Therapeutics: 'Sell' Rating On IPF Drug TTI-101 Advancement Uncertainty (TVRD) - Seeking Alpha Mon, 13 Oct 2025 07
- Veteran HR leader takes on culture and talent at global investor GCM Grosvenor - Stock Titan hu, 08 Jan 2026 08
- This ‘Strong Buy’ Stock Could Be the Next Big Biotech Breakout - Barchart.com Fri, 18 Jul 2025 07
- Shareholders sue to block Stamford-based Cara Therapeutics’ proposed merger with Houston biopharma firm - Hartford Business Journal Mon, 31 Mar 2025 07
- Cara Therapeutics Announces 1-for-12 Reverse Stock Split and Reduction in Authorized Shares - Nasdaq Fri, 27 Dec 2024 08
- Cara Therapeutics holds nine-figure stock sale - Stamford Advocate Mon, 29 Jul 2019 07
- Cara Therapeutics accepts buyout from Houston's Tvardi Therapeutics, ending 20-year run in Connecticut - CT Insider Wed, 18 Dec 2024 08
- Houston biotech biz to merge with public co., set local HQ - InnovationMap Mon, 30 Dec 2024 08
- Forget Cara Therapeutics' Earnings -- Here's the Real News - The Motley Fool hu, 17 May 2018 07
- Tvardi Therapeutics: A Critical Six-Month Horizon for Its Oncology Pipeline - AD HOC NEWS Wed, 11 Feb 2026 11
Insider Transactions
No recent insider transactions.
Financials
No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for CARA
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|